Skip to main content

Week In Review: AstraZeneca Considers Spinning Off China Ops Into Separate Company

Deals, financings, trials and approvals for the week ending June 23.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.